Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Phillip Jungwirths Recent Market Updates and Ratings

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
Finance_ Charts for stock trading
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

On March 12, 2024, Phillip Jungwirth, an analyst at BMO Capital, reaffirmed an Outperform rating for EQT (NYSE:EQT) and adjusted the price target from $42 to $40. Jungwirth’s recent market moves include raising Costco’s stock target to $800 and initiating Global Net Lease at Outperform. Additionally, he reiterated an Outperform rating for Integral Ad Science and Workiva, with adjustments to the price target for the latter.

EQT Stock Price Slightly Decreases on March 12, 2024: Factors to Consider for Investors

On March 12, 2024, EQT stock experienced a slight decrease in its price momentum. EQT opened at $34.78, which was $0.17 higher than its previous close. Throughout the day, the price of EQT shares dropped by $0.44, resulting in a 1.26% decrease.

This decline in stock price could be attributed to various factors such as market volatility, changes in industry trends, or company-specific news. Investors may have reacted to new information or developments that impacted their perception of EQT’s future prospects.

It is important for investors to closely monitor stock performances and stay informed about any updates or news that may affect their investment decisions. By staying informed and conducting thorough research, investors can make more informed choices about buying, selling, or holding onto their EQT shares.

Overall, while EQT experienced a slight decrease in stock price on March 12, 2024, it is essential for investors to consider the broader market context and company-specific factors before making any investment decisions.

EQT Stock Performance Analysis: Mixed Results for March 12, 2024

On March 12, 2024, EQT stock experienced mixed performances based on the latest financial data provided by CNN Money. The company’s total revenue for the past year was reported at $5.07 billion, which represented a significant decrease of 58.24% compared to the previous year. However, there was a positive trend in the fourth quarter, with total revenue increasing by 36.01% since the last quarter.

In terms of net income, EQT reported a net income of $1.74 billion for the past year and $502.06 million for the fourth quarter. The net income remained flat since the previous year and quarter, indicating a stable financial performance for the company.

Earnings per share (EPS) for EQT were reported at $4.22 for the past year and $1.13 for the fourth quarter. Although EPS decreased by 3.63% since the previous year, it held flat since the last quarter.

Overall, EQT stock showed a mix of positive and negative performances on March 12, 2024. Investors should closely monitor EQT’s financial performance and market trends to make informed decisions regarding their investments in the company.

Tags: EQT
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Roth MKM Analyst Maintains Neutral Rating on Kroger with Increased Price Target

Finances

Analyst Maintains Underperform Rating on Ballard Power Systems with Revised Price Target

Finance_Commercial

Bank of America Securities Analyst Maintains Buy Rating on MP Materials with Lowered Price Target

Recommended

Camping World Stock

Can Camping World Maintain Its Dividend Amid Market Pressures?

5 months ago
Trinity Biotech Stock

Trinity Biotech Faces Critical Nasdaq Compliance Deadline

5 months ago
DVY stock news

Amarin Strengthens Position and Maximizes Shareholder Value Through Share Repurchase Agreement with Cantor Fitzgerald

2 years ago
ASTeMobile Stock

ASTeMobile Shares Face Mounting Pressure as Investor Confidence Wanes

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Trending

Cassava Sciences Stock
Analysis

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

by Jackson Burston
February 8, 2026
0

The future of Cassava Sciences appears uncertain following the definitive termination of its Alzheimer's disease program. Detailed...

DroneShield Stock

DroneShield Shares Face Headwinds Despite Record Performance

February 8, 2026
Rock Tech Lithium Stock

Rock Tech Lithium: Investors Await the Final Go-Ahead

February 8, 2026
Puma Biotechnology Stock

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

February 8, 2026
Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays
  • DroneShield Shares Face Headwinds Despite Record Performance
  • Rock Tech Lithium: Investors Await the Final Go-Ahead

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com